Memphasys Ltd

MEM

Company Profile

  • Business description

    Memphasys Ltd is an Australian reproductive biotechnology company developing and commercializing novel reproduction and fertility solutions for humans and animals. The products in its development pipeline include a range of devices, media, and in vitro diagnostic solutions. The company is currently focused on the commercialisation of its patented Felix System, a novel bio-separation technology for assisted reproduction, designed to revolutionise sperm separation in assisted reproductive technology (ART) by providing a rapid, gentle, and automated process. The group has only one operating segment, being Reproductive Technologies, the assets and liabilities of which are located in Australia.

  • Contact

    34-36 Richmond Road
    Level 1
    Homebush West
    SydneyNSW2140
    AUS

    T: +61 284157300

    https://www.memphasys.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2026

    Employees

    28

Stocks News & Analysis

stocks

Unwarranted drop in ASX share

Jittery investors misinterpret an audit for an existential crisis.
stocks

Macquarie: A return to group-wide growth

Our view on the shares after earnings.
stocks

After earnings, is Disney stock a buy, a sell, or fairly valued? -

Following the highly anticipated announcement of a new CEO, here’s what we think of Disney.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,281.8097.301.06%
CAC 408,311.8915.99-0.19%
DAX 4024,950.2837.57-0.15%
Dow JONES (US)50,188.1452.270.10%
FTSE 10010,426.5172.670.70%
HKSE27,266.3883.230.31%
NASDAQ23,102.47136.20-0.59%
Nikkei 22557,650.541,286.602.28%
NZX 50 Index13,507.2860.910.45%
S&P 5006,941.8123.01-0.33%
S&P/ASX 2009,014.8098.801.11%
SSE Composite Index4,131.983.610.09%

Market Movers